ALLYSTA

allysta-logo

Allysta is a biopharmaceutical firm that develops peptide therapeutics with a focus on eye diseases.

#SimilarOrganizations #Financial #Website #More

ALLYSTA

Industry:
Biotechnology Health Care Medical Therapeutics

Address:
Bellevue, Washington, United States

Country:
United States

Website Url:
http://www.allysta.com

Status:
Active

Email Addresses:
[email protected]

Total Funding:
0

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business Wix Wix Forms Wix Hosted


Similar Organizations

curative-biotechnology-logo

Curative Biotechnology

Curative Biotechnology is a biopharmaceutical company that develops therapeutics, medical devices, and diagnostics.

kai-pharmaceuticals-logo

KAI Pharmaceuticals

KAI Pharmaceuticals discovers and develops novel therapeutics for cardiovascular diseases, kidney diseases and pain.

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

Investors List

morningside-technology-ventures_image

Morningside Venture Investments

Morningside Venture Investments investment in Series A - Allysta

Official Site Inspections

http://www.allysta.com

  • Host name: unalocated.63.wixsite.com
  • IP address: 185.230.63.186
  • Location: Ashburn United States
  • Latitude: 39.018
  • Longitude: -77.539
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20147

Loading ...

More informations about "Allysta"

Company | Allysta

She is the co-founder and COO of PRN Pharmaceutical Research Network, LLC, an ophthalmic-focused clinical research organization. Prior to founding PRN, Jeanette focused on …See details»

Allysta - Crunchbase Company Profile & Funding

Organization. Allysta . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Allysta is a biopharmaceutical company that develops therapeutic peptides for eye …See details»

Company | Allysta

Henry founded Allysta and serves as its CEO and President. He was a co-founder, CEO, and board member of Altheos, Inc., a private biopharmaceutical company in ophthalmic drug …See details»

Allysta Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...

Explore Allysta Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 1 news, and 7 literature, Disease Domain:Nervous System Diseases, Immune …See details»

Allysta Company Profile 2024: Valuation, Funding & Investors

Allysta General Information Description. Developer of anti-inflammatory and anti-fibrotic therapeutic peptides designed to treat eye diseases. The company offers an ophthalmic …See details»

Allysta Pharmaceuticals Company Profile | Management and

Allysta Pharmaceuticals Profile and History Allysta is a privately-held biopharmaceutical company developing first-in-class peptide therapeutics with a current focus in dry eye and liver diseases. …See details»

Allysta Pharmaceuticals, Inc. Company Profile | Andover, MA ...

Find company research, competitor information, contact details & financial data for Allysta Pharmaceuticals, Inc. of Andover, MA. Get the latest business insights from Dun & Bradstreet.See details»

Allysta Pharmaceuticals | VentureRadar

Allysta Pharmaceuticals is a private venture-backed clinical stage biopharmaceutical company. We are developing first-in-class therapeutic peptides that uniquely target adiponectin signaling …See details»

Allysta - Crunchbase

Allysta is a biopharmaceutical company that develops therapeutic peptides for eye diseases.See details»

Allysta - Company Profile - Tracxn

Nov 27, 2024 Allysta is developing therapies for eye diseases. The company has drug development programs for glaucoma and dry eye disease. The lead candidate, H1337 is a …See details»

Allysta - Funding, Financials, Valuation & Investors - Crunchbase

Allysta is a biopharmaceutical company that develops therapeutic peptides for eye diseases. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... How much …See details»

Allysta Pharmaceuticals - Products, Competitors, Financials, …

Allysta Pharmaceuticals is a clinical stage biopharmaceutical company developing medicines for rare diseases with unmet needs. The company focuses on therapeutic peptides that exhibit …See details»

Henry Hsu - CEO at Allysta - The Org

Henry founded Allysta and serves as its CEO and board member. He has extensive experience leading teams in all stages of drug development, from lead identification through Phase 3 NDA …See details»

Allysta Pharmaceuticals - Overview, News & Similar companies

Apr 24, 2019 Allysta is a privately-held biopharmaceutical company developing first-in-class peptide therapeutics with a current focus in dry eye and liver dise ases. The company's lead …See details»

Contact us - allysta

Allysta Pharmaceuticals, Inc. 500 108th Ave NE, Suite 1100, Bellevue, WA 98004 USA Allysta Pharmaceuticals, (Canada) Inc. 468 Queen Street East, Suite 201 Toronto, ON, MSA 1T7 …See details»

Allysta Pharmaceuticals - Craft

Allysta Pharmaceuticals is a biopharmaceutical company developing therapies for eye diseases. It offers therapeutic peptides that target adiponectin signaling pathways. Allysta's lead drug, …See details»

Allysta - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Organization. Allysta . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 3. Monthly Visits 78. …See details»

Science - allysta

Adipose tissue is not simply an inert storage depot for lipids but is also an important endocrine organ producing hormones that plays a key role in the integration of endocrine, metabolic, and …See details»

News - allysta

Allysta Pharmaceuticals, Inc. Announces Initiation of Dosing in OASIS-1 Phase 2b/3 Clinical Trial (ALY688-301 Study) Evaluating the Efficacy and Safety of ALY688 Ophthalmic Solution in Dry …See details»

linkstock.net © 2022. All rights reserved